Skip to main content

Synamatix Joins Illumina Connect Bioinformatics Program

NEW YORK (GenomeWeb News) – Synamatix said today that it has agreed to work with Illumina to develop and use its bioinformatics solutions for Illumina’s Genome Analyzer customers.
 
Synamatix said that it has joined the Illumina Connect program and will offer Genome Analyzer users data analysis applications using the SynaWorks platform.
 
Synamatix General Manager Arif Anwar noted that the company expects to work with Illumina on “a range of exciting genome and transcriptome sequencing projects in Asia, Europe, and North America.”
 

The Kuala Lumpur, Malaysia-based company also said that its software can be used for data analysis, identifying mutations, and prioritizing genetic analysis results, as well as moving, storing, and archiving data.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.